Actionable news
0
All posts from Actionable news
Actionable news in DVAX: Dynavax Technologies Corporation,

Biotech pops more than 70% after FDA panel greenlights hepatitis B vaccine

Dynavax stock rocketed up more than 70 percent in midday trading Monday after a FDA panel voted in favor of the company's primary drug under development.

The majority of an FDA advisory committee voted "yes" when asked whether data supports the safety of Dyanvax's Heplisav.

"[The] panel vote is a major win for Dynavax," J.P. Morgan analyst Anupam Rama wrote in a note. "We now believe that Heplisav has a high...


More